Cincinnati, OH, United States of America

Richard John Dansereau

This inventor holds 22 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: The Procter Gamble Company, Warner Chilcott Company, LLC, Norwich Eaton Pharmaceuticals, Inc.. Active years: 1991-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard John Dansereau. Retrieved from https://idiyas.com/inventor/richard-john-dansereau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 90.9

 

 

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 370(Granted Patents)


Location History:

  • Sherburne, NY (US) (1991 - 2003)
  • Mason, OH (US) (2000 - 2003)
  • Cilncinnati, OH (US) (2010)
  • Cincinnati, OH (US) (2010 - 2020)

Company Filing History:


Years Active: 1991-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Diphenhydramine
Pulsed Release
Phenylephrine
Bisphosphonates
Risedronate
Film-Coated Tablets
Oral Dosage Forms
Sodium Iodide
Dual-Action Tablet
Sinus Congestion
Gastrointestinal Safety
22 patents (USPTO):Explore Patents

Title: The Innovative Mind of Richard John Dansereau

Introduction:

Richard John Dansereau is a prolific inventor based in Cincinnati, OH, with an impressive track record of 22 patents to his name. His innovative solutions have revolutionized the field of pharmaceuticals, particularly in the realm of oral dosage forms for quick and effective drug delivery.

Latest Patents:

Dansereau's recent patents showcase his commitment to enhancing medical treatments through innovative delivery methods. One such invention is the 'Quick Dissolving Diphenhydramine Oral Dosage Form,' designed to deliver diphenhydramine rapidly through the sublingual or buccal mucosa. This oral dosage form includes permeability enhancers and buffering agents to ensure rapid dissolution within 2 minutes. Another notable patent is the 'Method for Relieving Sinus Congestion,' which involves a multi-particle pulsatile oral dosage form for combating sinus congestion and pressure effectively.

Career Highlights:

Dansereau has made significant contributions to renowned companies in the healthcare industry. He has lent his expertise to The Procter & Gamble Company and Warner Chilcott Company, LLC, where his innovative mindset has driven groundbreaking advancements in pharmaceutical technology.

Collaborations:

Collaboration is key to Dansereau's success, as evidenced by his partnerships with esteemed colleagues such as David Ernest Burgio, Jr, and Russell Youker Mosher. Together, they have worked on pioneering projects that have reshaped the landscape of drug delivery systems.

Conclusion:

Richard John Dansereau's dedication to innovation and his relentless pursuit of novel solutions have cemented his reputation as a trailblazer in the field of pharmaceutical inventions. His drive to improve medical treatments through inventive technologies continues to inspire and revolutionize the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…